Sally Barrington
King's College London
CancerInternal medicineRadiologyPET-CTPathologyMagnetic resonance imagingOncologyMedical physicsPositron emission tomographyABVDChemotherapyFollicular lymphomaFluorodeoxyglucoseDiffuse large B-cell lymphomaLymphomaMEDLINENuclear medicineHodgkin lymphomaRadiation therapyClinical trialMedicine
Publications 258
#1Colm J. McGinnity ('KCL': King's College London)H-Index: 11
#2Daniela A. Riaño Barros (South London and Maudsley NHS Foundation Trust)H-Index: 7
Last. Yusof Rahman (Guy's and St Thomas' NHS Foundation Trust)H-Index: 6
view all 0 authors...
We retrospectively examined the relationship between blood biomarkers, in particular the historical mean phenylalanine to tyrosine (Phe:Tyr) ratio, and cerebral glucose metabolism. We hypothesized that the historical mean Phe:Tyr ratio would be more predictive of cerebral glucose metabolism than the phenylalanine (Phe) level alone. We performed a retrospective case series analysis involving 11 adult classical phenylketonuria/hyperphenylalaninemia patients under the care of an Inherited Metabolic...
#1Sally Barrington ('KCL': King's College London)H-Index: 52
#2Amy A Kirkwood (UCL: University College London)H-Index: 21
view all 0 authors...
#1Stephen Booth (University of Oxford)H-Index: 4
#2Amy A KirkwoodH-Index: 21
Last. B. Phillips (MAHSC: Manchester Academic Health Science Centre)
view all 0 authors...
#1Elizabeth H. Phillips (University of Manchester)H-Index: 10
#2Nicholas Counsell (UCL: University College London)H-Index: 22
Last. Laura Clifton-Hadley (UCL: University College London)H-Index: 8
view all 0 authors...
#1Marialuisa Martelli (Sapienza University of Rome)H-Index: 19
#2Emanuele ZuccaH-Index: 3
Last. C. RusconiH-Index: 9
view all 0 authors...
#1Igor Aurer (University Hospital Centre Zagreb)H-Index: 18
#2Anouk Neven (European Organisation for Research and Treatment of Cancer)H-Index: 3
Last. Sally Barrington ('KCL': King's College London)H-Index: 52
view all 0 authors...
#1Julian M. M. Rogasch (Humboldt University of Berlin)H-Index: 10
#2Ronald BoellaardH-Index: 83
Last. Carsten Kobe (University of Cologne)H-Index: 30
view all 8 authors...
2 CitationsSource
#1Jakoba J EertinkH-Index: 2
Last. H.C.W. de Vet (PHRI: Public Health Research Institute)H-Index: 49
view all 25 authors...
Abstract Interim 18F-fluorodeoxyglucose positron emission tomography (Interim-18F-FDG-PET, hereafter I-PET) has the potential to guide treatment of patients with diffuse large B-cell lymphoma (DLBCL) if the prognostic value is known. The aim of this study was to determine the optimal timing and response criteria for evaluating prognosis with I-PET in DLBCL. Individual patient data from 1692 patients with de novo DLBCL were combined and scans were harmonized. I-PET was performed at various time p...
#1Tejas Kotwal ('KCL': King's College London)
#2Georgios Krokos ('KCL': King's College London)
Last. Barbara M. Fischer ('KCL': King's College London)H-Index: 23
view all 7 authors...
1439 Objectives: 18F-FDG PET is routinely used to assess glucose metabolism in tumours, providing information on the likelihood of malignancy and on response evaluation during treatment. FDG uptake in tissues not directly involved in disease can provide additional information on response and side-effects, but its clinical utility is largely unassessed due to the impracticality of manually segmenting organs on PET/CT. As a step towards an automated whole-body metabolic survey, we applied a 3D Con...
#1Sally Barrington ('KCL': King's College London)H-Index: 52
#2Jakoba J EertinkH-Index: 2
Last. Josée M. Zijlstra (VU: VU University Amsterdam)H-Index: 30
view all 6 authors...